Charles McWherter
CIK 1588862 · President of R&D · last filed 2025-10-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
34
Lifetime Open-Market Net
-$2.15M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| 89bio, Inc. (ETNB) Delisted | Director | 0 | $14.84 | $0 | $179.8K | 5 | 2025-10-30 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | President of R&D | 0 | $32.48 | $0 | -$2.33M | 26 | 2024-03-22 |
Recent Filings · Page 2 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-18 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$197.2K | EDGAR |
| 2023-09-19 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$244.0K | EDGAR |
| 2023-08-18 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$140.6K | EDGAR |
| 2023-07-19 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$139.8K | EDGAR |
| 2023-06-21 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$68.6K | EDGAR |
| 2023-05-19 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$88.6K | EDGAR |
| 2023-01-27 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-27 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-28 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-19 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.